P. Moreau

Publishing 2011

Is this you? Claim this profile
1
Article
236
Reads on Journament
18
Co-authors
1
Journal

This page collects the articles indexed under the name P. Moreau. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. Real-time control of the safety factor profile diagnosed by magneto-hydrodynamic activity on the Tore Supra tokamak
    nuclear fusion 2011 236 reads

Possible papers by P. Moreau 12

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. High frequency and high genetic diversity of Pneumocystis sp. in foals
    as Peggy Moreau medical mycology 2026
    Same name only
  2. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
    as Moreau P The Lancet. Oncology 2021
    Same name only
  3. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
    as Philippe Moreau Lancet (London, England) 2019
    Same name only
  4. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
    as Philippe Moreau The New England journal of medicine 2019 Emory University
    Same name only
  5. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.
    as Philippe Moreau leukemia 2019 Centre Hospitalier Universitaire de Nantes
    Same name only
  6. CAR-T cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network.
    as Philippe Moreau Haematologica 2019
    Same name only
  7. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
    as Philippe Moreau the lancet oncology 2016 Université de Nantes
    Same name only
  8. Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
    as Philippe Moreau Clinical Lymphoma Myeloma and Leukemia 2015
    Same name only
  9. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
    as Moreau P The New England journal of medicine 2014
    Same name only
  10. (2289) Proposal to conserve the name Morchella semilibera against Phallus crassipes, P. gigas and P. undosus (Ascomycota)
    as P.A. Moreau taxon 2014
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in